{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:18:09Z","timestamp":1764656289034,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recent studies have shown that increases in serum UA levels are associated with adverse clinical outcomes in patients with chronic heart failure (CHF); the aim of this study was to determine the relationship between serum uric acid and total diuretic dose received during hospitalization in hospitalized patients with acute exacerbation of heart failure. The main purpose of this study is to determine the role of uric acid as a biomarker that can be a substitute for pro-BNP in clinical evaluation and the need for diuretics in hospitalized patients with acute heart failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>After approving the plan in the Research Council of the Heart Department and obtaining an ethical code from the Regional Committee on Research Ethics (Human Subjects Studies), the researcher referred to the archives of our center, the case of 100 patients diagnosed with acute heart failure. Cardiac patients were selected, and the information required for the study was collected using a pre-prepared data collection form, and the information was entered into SPSS software after categorization and appropriate analysis and statistical tests were performed on it. Were performed and in all statistical tests the statistical significance level was considered 0.05:<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>100 patients with acute heart failure were included in this study with a mean age of 63.43\u2009\u00b1\u200914.78 years. 66% of them were men. The mean dose of furosemide in these patients was 680.92\u2009\u00b1\u2009377.47\u00a0mg and the mean serum uric acid level in these patients was 8.55\u2009\u00b1\u20092.50\u00a0mg \/ dL. In the study of the relationship between the variables, there was a significant relationship between the dose of furosemide received with the serum level of serum uric acid (<jats:italic>P<\/jats:italic>\u2009=\u20090.017, r\u2009=\u20090.248 and <jats:italic>P<\/jats:italic>\u2009=\u20090.009, r = -0.267, respectively). There is also a significant relationship between serum uric acid level and patient mortality (<jats:italic>P<\/jats:italic>\u2009=\u20090.013, r\u2009=\u20090.247). However this relationship lost its significance after multivariate analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There is a significant relationship between serum uric acid level and diuretic use. However, in-hospital mortality is not related to uric acid levels at admission.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03687-w","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T21:13:48Z","timestamp":1704316428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Could admission level of uric acid predict total diuretic dose in acute heart failure?"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2376-0913","authenticated-orcid":false,"given":"Maryam","family":"Chenaghlou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4797-3427","authenticated-orcid":false,"given":"Fatemeh Abedi","family":"mahzoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-4885","authenticated-orcid":false,"given":"Sina","family":"Hamzehzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1825-272X","authenticated-orcid":false,"given":"Ali","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8877-7882","authenticated-orcid":false,"given":"Hadi","family":"Sahrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5009-3538","authenticated-orcid":false,"given":"Nasibeh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1968-1533","authenticated-orcid":false,"given":"Negin Khadem","family":"haghighi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2444-1172","authenticated-orcid":false,"given":"Mirsaeed","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9577-0099","authenticated-orcid":false,"given":"Mohammadreza Taban","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7825-2759","authenticated-orcid":false,"given":"Erfan","family":"Banisefid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"issue":"1","key":"3687_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccep.2018.11.001","volume":"11","author":"D Snipelisky","year":"2019","unstructured":"Snipelisky D, Chaudhry SP, Stewart GC. The many faces of Heart Failure. Card Electrophysiol Clin. 2019;11(1):11\u201320.","journal-title":"Card Electrophysiol Clin"},{"issue":"2\u20133","key":"3687_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0167-5273(01)00497-1","volume":"80","author":"GF Mendez","year":"2001","unstructured":"Mendez GF, Cowie MR. The epidemiological features of Heart Failure in developing countries: a review of the literature. Int J Cardiol. 2001;80(2\u20133):213\u20139.","journal-title":"Int J Cardiol"},{"issue":"11","key":"3687_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","volume":"17","author":"JP Goetze","year":"2020","unstructured":"Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17(11):698\u2013717.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"3687_CR4","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr., Colvin MM, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137\u2013e61.","journal-title":"Circulation"},{"issue":"3","key":"3687_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMoa020233","volume":"347","author":"AS Maisel","year":"2002","unstructured":"Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of Heart Failure. N Engl J Med. 2002;347(3):161\u20137.","journal-title":"N Engl J Med"},{"issue":"19","key":"3687_CR6","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.jacc.2007.02.037","volume":"49","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated Heart Failure. J Am Coll Cardiol. 2007;49(19):1943\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3687_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/archinte.166.3.315","volume":"166","author":"JL Januzzi Jr","year":"2006","unstructured":"Januzzi JL Jr., Sakhuja R, O\u2019Donoghue M, Baggish AL, Anwaruddin S, Chae CU, et al. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med. 2006;166(3):315\u201320.","journal-title":"Arch Intern Med"},{"issue":"3","key":"3687_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","volume":"27","author":"JL Januzzi","year":"2006","unstructured":"Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized Heart Failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP study. Eur Heart J. 2006;27(3):330\u20137.","journal-title":"Eur Heart J"},{"issue":"20","key":"3687_CR9","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1056\/NEJMra021498","volume":"348","author":"M Jessup","year":"2003","unstructured":"Jessup M, Brozena S. Heart Failure. N Engl J Med. 2003;348(20):2007\u201318.","journal-title":"N Engl J Med"},{"issue":"5","key":"3687_CR10","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/jama.287.5.628","volume":"287","author":"A Nohria","year":"2002","unstructured":"Nohria A, Lewis E, Stevenson LW. Medical management of advanced Heart Failure. JAMA. 2002;287(5):628\u201340.","journal-title":"JAMA"},{"issue":"4","key":"3687_CR11","first-page":"403","volume":"51","author":"MS Figueroa","year":"2006","unstructured":"Figueroa MS, Peters JI. Congestive Heart Failure: diagnosis, pathophysiology, therapy, and implications for respiratory care. Respir Care. 2006;51(4):403\u201312.","journal-title":"Respir Care"},{"issue":"1","key":"3687_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident Hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63(1):102\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3687_CR13","doi-asserted-by":"publisher","first-page":"852954","DOI":"10.1155\/2014\/852954","volume":"2014","author":"L Billiet","year":"2014","unstructured":"Billiet L, Doaty S, Katz JD, Velasquez MT. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol. 2014;2014:852954.","journal-title":"ISRN Rheumatol"},{"issue":"7","key":"3687_CR14","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.amjcard.2017.06.057","volume":"120","author":"A Palazzuoli","year":"2017","unstructured":"Palazzuoli A, Ruocco G, De Vivo O, Nuti R, McCullough PA. Prevalence of Hyperuricemia in patients with Acute Heart Failure with either reduced or preserved ejection fraction. Am J Cardiol. 2017;120(7):1146\u201350.","journal-title":"Am J Cardiol"},{"key":"3687_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.metabol.2018.02.007","volume":"83","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, et al. Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic Heart Failure: a post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza Nella Insufficienza Cardiaca-Heart failure) trial. Metabolism. 2018;83:205\u201315.","journal-title":"Metabolism"},{"issue":"1","key":"3687_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1751-7133.2011.00200.x","volume":"17","author":"L Tamariz","year":"2011","unstructured":"Tamariz L, Harzand A, Palacio A, Verma S, Jones J, Hare J. Uric acid as a predictor of all-cause mortality in Heart Failure: a meta-analysis. Congest Heart Fail. 2011;17(1):25\u201330.","journal-title":"Congest Heart Fail"},{"issue":"4","key":"3687_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jacc.2008.10.023","volume":"53","author":"AP Kalogeropoulos","year":"2009","unstructured":"Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Smith AL, Agha SA, Waheed S, et al. Utility of the Seattle Heart Failure Model in patients with advanced Heart Failure. J Am Coll Cardiol. 2009;53(4):334\u201342.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3687_CR18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/eurjhf\/hfr030","volume":"13","author":"L Manzano","year":"2011","unstructured":"Manzano L, Babalis D, Roughton M, Shibata M, Anker SD, Ghio S, et al. Predictors of clinical outcomes in elderly patients with Heart Failure. Eur J Heart Fail. 2011;13(5):528\u201336.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"3687_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.semarthrit.2011.02.002","volume":"41","author":"D Misra","year":"2011","unstructured":"Misra D, Zhu Y, Zhang Y, Choi HK. The Independent impact of Congestive Heart Failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study. Semin Arthritis Rheum. 2011;41(3):471\u20136.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"3687_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.12669\/pjms.332.11779","volume":"33","author":"A Khan","year":"2017","unstructured":"Khan A, Shah MH, Khan S, Shamim U, Arshad S. Serum uric acid level in the severity of Congestive Heart Failure (CHF). Pak J Med Sci. 2017;33(2):330\u20134.","journal-title":"Pak J Med Sci"},{"issue":"4","key":"3687_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1536\/ihj.17-522","volume":"59","author":"Y Yao","year":"2018","unstructured":"Yao Y, Zhang J, Zhang Y, Zhang R. Can Torsemide and Combination of Loop Diuretics improve mortality in patients with chronic Heart Failure after discharge? Int Heart J. 2018;59(4):813\u201320.","journal-title":"Int Heart J"},{"issue":"4","key":"3687_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.numecd.2019.01.001","volume":"29","author":"HB Zhou","year":"2019","unstructured":"Zhou HB, Xu TY, Liu SR, Bai YJ, Huang XF, Zhan Q, et al. Association of serum uric acid change with mortality, renal function and diuretic dose administered in treatment of acute Heart Failure. Nutr Metab Cardiovasc Dis. 2019;29(4):351\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5 Suppl","key":"3687_CR23","first-page":"I74","volume":"13","author":"S Yusuf","year":"1989","unstructured":"Yusuf S, Thom T, Abbott RD. Changes in Hypertension treatment and in Congestive Heart Failure mortality in the United States. Hypertension. 1989;13(5 Suppl):I74\u20139.","journal-title":"Hypertension"},{"issue":"26","key":"3687_CR24","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of Congestive Heart Failure: the Framingham study. N Engl J Med. 1971;285(26):1441\u20136.","journal-title":"N Engl J Med"},{"issue":"36","key":"3687_CR25","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1093\/eurheartj\/ehac320","volume":"43","author":"W Doehner","year":"2022","unstructured":"Doehner W, Anker SD, Butler J, Zannad F, Filippatos G, Ferreira JP, et al. Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in Heart Failure with reduced ejection fraction: the EMPEROR-reduced trial. Eur Heart J. 2022;43(36):3435\u201346.","journal-title":"Eur Heart J"},{"issue":"8","key":"3687_CR26","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1253\/circj.70.1006","volume":"70","author":"H Sakai","year":"2006","unstructured":"Sakai H, Tsutamoto T, Tsutsui T, Tanaka T, Ishikawa C, Horie M. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with Congestive Heart Failure. Circ J. 2006;70(8):1006\u201311.","journal-title":"Circ J"},{"issue":"5","key":"3687_CR27","doi-asserted-by":"publisher","first-page":"L830","DOI":"10.1152\/ajplung.00007.2008","volume":"294","author":"A Boueiz","year":"2008","unstructured":"Boueiz A, Damarla M, Hassoun PM. Xanthine oxidoreductase in respiratory and cardiovascular disorders. Am J Physiol Lung Cell Mol Physiol. 2008;294(5):L830\u201340.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"Pt 3","key":"3687_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","volume":"555","author":"CE Berry","year":"2004","unstructured":"Berry CE, Hare JM. Xanthine oxidoreductase and Cardiovascular Disease: molecular mechanisms and pathophysiological implications. J Physiol. 2004;555(Pt 3):589\u2013606.","journal-title":"J Physiol"},{"issue":"11","key":"3687_CR29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","volume":"99","author":"M Kanbay","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human Cardiovascular Disease. Heart. 2013;99(11):759\u201366.","journal-title":"Heart"},{"key":"3687_CR30","doi-asserted-by":"publisher","first-page":"785327","DOI":"10.3389\/fmed.2021.785327","volume":"8","author":"L Miao","year":"2021","unstructured":"Miao L, Guo M, Pan D, Chen P, Chen Z, Gao J, et al. Serum uric acid and risk of Chronic Heart Failure: a systematic review and Meta-analysis. Front Med (Lausanne). 2021;8:785327.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"3687_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jjcc.2016.04.013","volume":"68","author":"H Okazaki","year":"2016","unstructured":"Okazaki H, Shirakabe A, Kobayashi N, Hata N, Shinada T, Matsushita M, et al. The prognostic impact of uric acid in patients with severely decompensated acute Heart Failure. J Cardiol. 2016;68(5):384\u201391.","journal-title":"J Cardiol"},{"issue":"2","key":"3687_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/HJH.0000000000002600","volume":"39","author":"A Maloberti","year":"2021","unstructured":"Maloberti A, Bombelli M, Facchetti R, Barbagallo CM, Bernardino B, Rosei EA, et al. Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid right for heArt Health study. J Hypertens. 2021;39(2):333\u201340.","journal-title":"J Hypertens"},{"key":"3687_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejim.2022.01.018","volume":"99","author":"P Rebora","year":"2022","unstructured":"Rebora P, Centola M, Morici N, Sacco A, Occhino G, Viola G, et al. Uric acid associated with acute Heart Failure presentation in Acute Coronary Syndrome patients. Eur J Intern Med. 2022;99:30\u20137.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"3687_CR34","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1046\/j.1523-1755.2003.00273.x","volume":"64","author":"N Vasavada","year":"2003","unstructured":"Vasavada N, Agarwal R. Role of excess volume in the pathophysiology of Hypertension in chronic Kidney Disease. Kidney Int. 2003;64(5):1772\u20139.","journal-title":"Kidney Int"},{"issue":"3","key":"3687_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11897-004-0021-8","volume":"1","author":"CW Yancy","year":"2004","unstructured":"Yancy CW, Fonarow GC. Quality of care and outcomes in acute decompensated Heart Failure: the ADHERE Registry. Curr Heart Fail Rep. 2004;1(3):121\u20138.","journal-title":"Curr Heart Fail Rep"},{"issue":"10","key":"3687_CR36","doi-asserted-by":"publisher","first-page":"e0240098","DOI":"10.1371\/journal.pone.0240098","volume":"15","author":"Z Bl\u00e1zquez-Bermejo","year":"2020","unstructured":"Bl\u00e1zquez-Bermejo Z, Farr\u00e9 N, Llagostera M, Caravaca Perez P, Mor\u00e1n-Fern\u00e1ndez L, Fort A, et al. The development of chronic diuretic resistance can be predicted during a Heart-Failure hospitalization. Results from the REDIHF registry. PLoS ONE. 2020;15(10):e0240098.","journal-title":"PLoS ONE"},{"issue":"11","key":"3687_CR37","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cardfail.2020.07.002","volume":"26","author":"H Yamamoto","year":"2020","unstructured":"Yamamoto H, Nagatomo Y, Mahara K, Yoshikawa T. In-Hospital serum uric acid change predicts adverse outcome in patients with Heart Failure. J Card Fail. 2020;26(11):968\u201376.","journal-title":"J Card Fail"},{"issue":"6730","key":"3687_CR38","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/bmj.300.6730.975","volume":"300","author":"JE Carlsen","year":"1990","unstructured":"Carlsen JE, K\u00f8ber L, Torp-Pedersen C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ. 1990;300(6730):975\u20138.","journal-title":"BMJ"},{"issue":"6","key":"3687_CR39","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","volume":"41","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in Hypertension and cardiovascular and renal Disease? Hypertension. 2003;41(6):1183\u201390.","journal-title":"Hypertension"},{"issue":"12","key":"3687_CR40","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/0895-4356(90)90095-7","volume":"43","author":"HM Loenen","year":"1990","unstructured":"Loenen HM, Eshuis H, L\u00f6wik MR, Schouten EG, Hulshof KF, Odink J, et al. Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch Nutrition Surveillance System). J Clin Epidemiol. 1990;43(12):1297\u2013303.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"3687_CR41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","volume":"34","author":"AP Ambrosy","year":"2013","unstructured":"Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of Heart Failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34(11):835\u201343.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03687-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03687-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03687-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T21:16:40Z","timestamp":1704316600000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03687-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03687-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"26 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study process was reviewed and approved by the ethics committee of Tabriz University of Medical Sciences, according to the declaration of Helsinki (ethics code: IR.TBZMED.REC.1400.513). before collecting data, informed consent was obtained from all patients. all methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"No conflict of interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}